BioSig Technologies Announces CFO Transition and New Appointment
Company Announcements

BioSig Technologies Announces CFO Transition and New Appointment

BioSig Technologies (BSGM) has provided an update.

BioSig Technologies, Inc. has appointed Ferdinand Groenewald as their interim chief financial officer and principal accounting officer, following the resignation of Frederick D. Hrkac. Groenewald, who brings extensive financial leadership experience from previous roles at Alaunos Therapeutics, Muscle Maker, Inc., and directorships at other Nasdaq-listed companies, will manage the company’s accounting and financial reporting under a consulting agreement. His compensation includes a monthly rate of $15,000 plus reimbursement for business expenses, with the option for either party to terminate the agreement with 30 days’ notice. The company publicized Groenewald’s new role in a recent press release.

For an in-depth examination of BSGM stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyBioSig Technologies to resume trading on Nasdaq following successful appeal
TipRanks Auto-Generated NewsdeskBioSig Technologies Announces Executive Leadership Overhaul
TheFlyBioSig Technologies announces intent to acquire Nuero-Kinesis assets
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App